Jazz says it will acquire Celator
MLex summary: Dublin-based Jazz Pharmecuticals said on Tuesday it will acquire Celator Pharmaceuticals for about $1.5 billion in cash. The transaction woulg give Jazz a drug in development that will be...To view the full article, register now.
Already a subscriber? Click here to view full article